Investor Strategies For Dealing With Startup Failure

Nine out of ten startups fail—and yet the smartest investors keep writing checks anyway. That paradox is at the heart of this piece, which digs into what really happens when a promising venture starts circling the drain, and how angel investors should respond when the data turns ugly.

The article breaks down the anatomy of failure with refreshing honesty. Seventy percent of startups collapse because they run out of cash before securing new funding, while nearly a third simply enter the market at the wrong time. But beyond the obvious culprits—funding gaps and timing—the piece rightly points to something I talk about constantly with founders: team dysfunction. A brilliant product can't survive a leadership team that won't listen to each other or lacks basic financial literacy.

Spotting the red flags early

What I appreciated most is the emphasis on pattern recognition. Failure isn't a single dramatic event—it's a slow accumulation of small missteps: founders obsessing over product while ignoring market feedback, or burning through capital without any reserve strategy. The author's advice to track sales figures, user growth and partner feedback as early warning signals is exactly the kind of disciplined due diligence I push entrepreneurs to anticipate before they ever step into a pitch room.

The practical checklist for investors facing a sinking portfolio company is solid: assess what was controllable, consider salvaging assets, and use the experience to sharpen future due diligence. Strengthening your vetting process after a loss isn't pessimism—it's maturity.

Where the article really lands is its reframing of failure as tuition, not tragedy. The author's admission that early disappointments as an investor made them sharper and more analytical mirrors what I see constantly in this ecosystem—resilience and reflection separate the professionals from the tourists. Even unicorns like Uber and Airbnb emerged from investor portfolios littered with quiet failures nobody remembers.

This is a grounded, no-nonsense read for anyone writing checks into early-stage companies. Give the full article a look if you want a clearer framework for recognizing trouble before it metastasizes.